GoldenGolden
Advanced Search
Relypsa

Relypsa

A biopharmaceutical company developing drugs to treat cardiovascular and renal diseases

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

August 14, 2012
Relypsa raises a $80,000,000 series C round from 5AM Ventures, Delphi Ventures, Mediphase Venture Partners, New Leaf Venture Partners, OrbiMed Advisors, Sibling Capital and Sprout Group.
October 29, 2007
Relypsa raises a $33,000,000 series A round from 5AM Ventures and Delphi Ventures.

Funding rounds

People

Name
Role
LinkedIn

Anil Yemmanuru

Employee

Bailey Snooks

Employee

Bill Long

Investor

Jennifer Buttrey, PMP

Employee

Johnny Lovelady

Employee

Maria Baker

Employee

Meghan Lloyd

Employee

Melissa Donahue

Employee

Michael Rogers

Employee

Nathan Cheng

Employee

Nina Hill

Employee

shyam babu kuriseti

Employee

Steven Hill

Employee

Vadim Paluy, MD

Employee

Victor Nava-Salgado

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.